cancer refractory Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1/2 (2)
Phase 2 (1)

Interventional (3)

Massachusetts General Hospital (1)
National Cancer Institute (NCI) (1)
Shenzhen Geno-Immune Medical Institute (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadproto-oncogene tyrosine-protein kinase ros

I am/have/haddonor lymphocyte infusion

I am/have/hadcns tumors

I am/have/hadmedulloblastoma

I am/have/hadnon-hodgkin lymphoma

I am/have/hadglomerular filtration rate

I am/have/hadplatelet transfusions

I am/have/hadhodgkin's disease

I am/have/hadrefractory peripheral primitive neuroectodermal tumor

I am/have/hadrefractory malignant glioma

I am/have/hadpleural effusion

I am/have/hadrhabdomyosarcoma recurrent

I am/have/hadradiopharmaceutical therapy

I am/have/hadrecurrent childhood medulloblastoma

I am/have/hadseizure

I am/have/haddrug test

I am/have/hadmetastatic disease

I am/have/hadmyelosuppressive chemotherapy

I am/have/hadcytotoxic chemotherapy

I am/have/hadrecurrent langerhans cell histiocytosis

added new label for I am/have/had

I am looking for

I am looking forbinimetinib

I am looking forantiepileptics

I am looking forhematopoietic growth factors

I am looking forlacosamide

I am looking forantineoplastic

I am looking fornitrosoureas

I am looking fortumor markers

I am looking for131i-mibg

I am looking forchemotherapeutic agents

I am looking forcombinations

I am looking forkinase inhibitor

I am looking foriobenguane

I am looking foranticancer agents

I am looking forcrizotinib

I am looking forgrowth factor

I am looking forinterferon

I am looking forpediatric

I am looking foranticonvulsants

I am looking forlevetiracetam

I am looking forantineoplastic agents

added new label for I am looking for

Advanced Filters

Found 5 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

None

None views

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Lorlatinib Combinations in Lung Cancer

This research study is evaluating Lorlatinib in combination with Crizotinib or Binimetinib as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves three study drugs. Lorlatinib Binimetinib Crizotinib

ascites

cns metastases

proto-oncogene tyrosine-protein kinase ros

binimetinib

antiepileptics

0 views
16 Feb, 2024
2 locations

Phase 1
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Multi-CAR-T Cells Targeting B Cell Lymphomas

This study aims to evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting B cell surface molecules including CD19 and alternative CARTs as booster and consolidation treatment for patients with highly resistant B cell lymphomas, including primary mediastinal B cell lymphoma (PMBCL) …

0 views
16 Feb, 2024
3 locations

Phase 2
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

cns tumors

medulloblastoma

non-hodgkin lymphoma

glomerular filtration rate

hematopoietic growth factors

0 views
16 Feb, 2024
83 locations